Thrombolytic therapy before percutaneous coronary intervention improves short-term cardiac function evaluated by

Jiani Yin1,2, Hao Gong1, Yunfei Wang1

  • 1Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, PR China.

Insights

Half-dose recombinant staphylokinase (r-SAK) before percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) patients improved cardiac function and strain without increasing adverse events.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Imaging

Background:

  • Thrombolytic therapy before percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is debated.
  • Further research is needed to assess the benefits of pre-PCI thrombolysis.

Purpose of the Study:

  • To evaluate the efficacy of a half-dose recombinant staphylokinase (r-SAK) intravenous bolus administered before PCI in STEMI patients.

Main Methods:

  • STEMI patients were randomized to receive either r-SAK or normal saline before PCI.
  • Cardiac magnetic resonance (CMR) assessed cardiac function, myocardial characteristics, and strain at 5 days post-MI.
  • Segments were categorized by late gadolinium enhancement (LGE) extent.

Main Results:

  • The r-SAK group (n=33) showed improved left ventricular ejection fraction and cardiac output index compared to the normal saline group (n=31).
  • No significant differences were observed in infarct size, area at risk, microvascular obstruction (MVO), or intramyocardial hemorrhage (IMH).
  • Patients receiving r-SAK demonstrated significantly better segmental longitudinal strain and improved segmental circumferential strain in LGE segments.

Conclusions:

  • A single half-dose r-SAK bolus before PCI in STEMI patients improved short-term cardiac function and strain.
  • This approach did not increase the incidence of MVO or IMH, suggesting a favorable safety profile.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
429
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.5K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
391
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
407
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
630